Will this drug be the first treatment for NASH?
There has been some success in a clinical trial but specialists flag safety issues
10th December 2019
By Clare Pain
Interim results from a clinical trial of obeticholic acid for non-alcoholic steatohepatitis (NASH) show it significantly reduces fibrosis and will probably confer clinical benefit, international researchers report.